Reuters logo
BRIEF-Alector and AbbVie announce collaboration
October 24, 2017 / 11:19 AM / a month ago

BRIEF-Alector and AbbVie announce collaboration

Oct 24 (Reuters) - AbbVie Inc

* Alector and AbbVie announce collaboration to advance a novel class of immune therapies for patients with Alzheimer’s disease

* AbbVie Inc - ‍Alector and AbbVie will co-fund development and commercialization and will share global profits equally​

* AbbVie Inc - ‍Alector will receive a $205 million upfront payment and a potential, future equity investment of up to $20 million​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below